RK-287107 [2171386-10-8]

Cat# NB-64-07762-5mg

Size : 5mg

Brand : Neo Biotech

Contact local distributor :


Phone : +1 850 650 7790

RK-287107

Catalog No. T16761 Copy Product Info
Purity: 99.64%
RK-287107 is an effective and specific inhibitor of tankyrase (IC50s: 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively).

RK-287107

Copy Product Info

RK-287107 is an effective and specific inhibitor of tankyrase (IC50s: 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively).

RK-287107
Cas No. 2171386-10-8
TargetMol | Customer service
Customer service consultation
Select Batch
Purity:99.64%
Appearance:Solid
Color:White
Contact us for more batch information

Product Introduction

Bioactivity
Description
RK-287107 is an effective and specific inhibitor of tankyrase (IC50s: 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively).
Targets&IC50
Tankyrase 1:14.3 nM, Tankyrase 2:10.6 nM
In vitro
RK-287107 (0.03-10 μM; 16 hours) also downregulates β-catenin signaling in cultured cells. 287107 (0.03-10 μM; 16 hours) induces the accumulation of tankyrase and Axin1/2. RK-87107 (0.01-10 μM; 12 hours) displays an antiproliferative effect on colorectal cancer cells harboring short adenomatous polyposis coli mutations. The 50% growth inhibition (GI50) value of RK-287107 on COLO-320DM cells is 0.449 μM. RK- [1].
In vivo
In a mouse xenograft model, RK-287107 (100 and 300 mg/kg; i.p. administration; once per day; 5-days on/ 2-days off schedule for 2 weeks) inhibits tumor growth [1].
Chemical Properties
Molecular Weight416.46
FormulaC22H26F2N4O2
Cas No.2171386-10-8
SmilesOCCN1CC2(CCN(CC2)c2nc3CCCCc3c(=O)[nH]2)c2c1cc(F)cc2F
Relative Density.1.48 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 120 mg/mL (288.14 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (9.6 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4012 mL12.0060 mL24.0119 mL120.0595 mL
5 mM0.4802 mL2.4012 mL4.8024 mL24.0119 mL
10 mM0.2401 mL1.2006 mL2.4012 mL12.0060 mL
20 mM0.1201 mL0.6003 mL1.2006 mL6.0030 mL
50 mM0.0480 mL0.2401 mL0.4802 mL2.4012 mL
100 mM0.0240 mL0.1201 mL0.2401 mL1.2006 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

You might also be interested by the following products:



Cat#
Description
Cond.
Price Bef. VAT
NB-64-06877-50mg
 50mg 
NB-64-08018-50mg
 50mg 
NB-64-00336-50mg
 50mg